Cystic Fibrosis Trust offers grants up to £350 for items or services that improve the health and wellbeing of people living with cystic fibrosis. Apply now.
ReCode Therapeutics Inc. has developed a potential new genetic therapy (RCT2100) for cystic fibrosis. RCT2100 is an inhaled treatment that mimics a natural substance in the body that makes the CFTR protein and may lead to the production of functional CFTR protein and help prevent further damage to the lungs. Part 1 of the study tested RCT2100 in people without CF to determine doses to test in the remainder of the study. We are now recruiting people with CF for Part 2. In Part 2 of the study we will test the safety of different dose levels of RCT2100 in...
This CF Week, we chatted to Adam, 19, about daily life with CF, what he wishes more people understood about the condition, and how support from Cystic Fibrosis Trust has helped him.
This CF Week, Catherine tells us about her journey to competitive cheerleading – from the challenges to the triumphs – and how CF has affected her along the way.
This year’s CF Week theme draws attention to the different realties people with CF experience. CF is so much more than the lungs: it’s a lifelong, life-limiting condition that impacts the whole body, and one area that is impacting more people with CF is the liver.
CF Week might be over, but we’re here for everyone affected by cystic fibrosis, today, tomorrow and every day after. Here are just some of the ways we can support you.
